Acadian Asset Management LLC Relmada Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
A detailed history of Acadian Asset Management LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 619,479 shares of RLMD stock, worth $365,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
619,479
Previous 1,227,928
49.55%
Holding current value
$365,492
Previous $329,000
12.77%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RLMD
# of Institutions
55Shares Held
5.43MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$436,6030.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$338,2550.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$233,9430.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$214,8050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA302KShares$178,3880.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $16.9M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...